Promising Indicators in Probiotic-recommendations in COVID-19 and its Accompanying Diseases | Zendy

Vardan Tsaturyan | Zendy; Аlmagul Kushugulova | Zendy; Susanna Mirzabekyan | Zendy; Ketevan Sidamonidze | Zendy; David Tsereteli | Zendy; Tamás Török | Zendy; Astghik Pepoyan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Promising Indicators in Probiotic-recommendations in COVID-19 and its Accompanying Diseases

Author(s) -

Vardan Tsaturyan,

Аlmagul Kushugulova,

Susanna Mirzabekyan,

Ketevan Sidamonidze,

David Tsereteli,

Tamás Török,

Astghik Pepoyan

Publication year - 2022

Publication title -

open access macedonian journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.288

H-Index - 17

ISSN - 1857-9655

DOI - 10.3889/oamjms.2022.7989

Subject(s) - probiotic , medicine , covid-19 , disease , intensive care medicine , infectious disease (medical specialty) , pathology , biology , genetics , bacteria

Scientific data suggests the possible beneficial role of probiotics in treatments for COVID-19, but the species/strains-specificity and disease-specificity of probiotics need high attention in choosing the appropriate probiotic in diseases, in particularly in the COVID-19. We hope this review will raise awareness of the COVID-19 probiotic recommendations, highlighting the latest scientific information about virus/hydrogen peroxide/probiotics and the importance of finding out of a specific “criterion” for the probiotics’ recommendation in this disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research